NBE Therapeutics has continuously built relationships and established value-adding partnerships with groups at top-tier academic institutions, like ETH-Zurich, Switzerland, The Scripps Research Institute, U.S., the University Clinics Basel, Switzerland, and the University of Erlangen, Germany, to mention a few. Together with these selected academic partners the in-house developed capabilities of the company can optimally be leveraged for achieving the development goals of NBE-Therapeutics.
In addition, NBE-Therapeutics has also entered into value-adding strategic collaborations with industry-partners, like Sotio a.s., Czech Republic, part of the PPF Group, that has more than € 20 billion capital under management.
- Basel, 2017-11-28 - NBE-Therapeutics appoints Dr. Nicole Onetto to its Board of Directors
- Lisbon, Portugal, 2017-11-14 - NBE-Therapeutics presented update on R&D activities at 2017-PEGS conference
- Basel, Switzerland, 2017-11-02 - NBE-Therapeutics presented update on R&D activities at 2017 HPAPI World Congress